Balance Sheet
AssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityOther Non-Current AssetsOther Non-Current LiabilitiesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fresenius Medical Care AG (FMS) Cash & Equivalents: 2009-2024

Historic Revenue - Interest and Investment Income for Fresenius Medical Care AG (FMS) over the last 2 years, with Q1 2014 value amounting to $9.7 billion.

  • Fresenius Medical Care AG's Cash & Equivalents fell 360.17% to $1.5 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $1.5 billion, marking a year-over-year decrease of 360.17%. This contributed to the annual value of $1.3 billion for FY2024, which is 1645.49% down from last year.
  • As of Q3 2025, Fresenius Medical Care AG's Cash & Equivalents stood at $1.5 billion, which was down 360.17% from $1.9 billion recorded in Q2 2025.
  • Over the past 5 years, Fresenius Medical Care AG's Cash & Equivalents peaked at $1.9 billion during Q2 2025, and registered a low of $1.1 billion during Q2 2022.
  • Over the past 5 years, Fresenius Medical Care AG's median Cash & Equivalents value was $1.3 billion (recorded in 2022), while the average stood at $1.4 billion.
  • Its Cash & Equivalents has fluctuated over the past 5 years, first plummeted by 3904.14% in 2022, then soared by 6213.9% in 2025.
  • Over the past 2 years, Fresenius Medical Care AG's Revenue - Interest and Investment Income (Quarter) stood at $9.1 billion in 2013, then increased by 6.41% to $9.7 billion in 2014.
  • Its last three reported values are $1.5 billion in Q3 2025, $1.9 billion for Q2 2025, and $1.1 billion during Q1 2025.